Safety, correlative markers, and clinical results of adjuvant nivolumab in combination with vaccine in resected high-risk metastatic melanoma
Gibney, Geoffrey T, Kudchadkar, Ragini R, DeConti, Ronald C, Thebeau, Melissa S, Czupryn, Maria P, Tetteh, Leticia, Eysmans, Cabell, Richards, Allison, Schell, Michael J, Fisher, Kate J, Horak, Christine E, Inzunza, H David, Yu, Bin, Martinez, Alberto J, Younos, Ibrahim, Weber, Jeffrey S
Published in Clinical cancer research (15.02.2015)
Published in Clinical cancer research (15.02.2015)
Get full text
Journal Article
Adjuvant nivolumab (NIVO) plus ipilimumab (IPI) for resected high-risk stages IIIC/IV melanoma (MEL)
Khushalani, Nikhil I., Kim, Youngchul, Gibney, Geoffrey Thomas, Kudchadkar, Ragini Reiney, Eroglu, Zeynep, Markowitz, Joseph, Czupryn, Maria P., Thebeau, Melissa S., McCormick, Lori, Richards, Allison, Weber, Jeffrey S.
Published in Journal of clinical oncology (20.05.2016)
Published in Journal of clinical oncology (20.05.2016)
Get full text
Journal Article